Post by
ISAloser247 on May 22, 2012 5:51pm
"A new batch of voclosporin has been ordered from
and should be ready for patient use in the first half of 2012." "Importantly, we have already secured funding for the North American trial through our strategic partner Iljin Life Sciences." Letter to the Shareholders Nov. 1 ,2011. . with such concientious truthfulness and honesty, it is no wonder that the share price and volumes are at todays' level! Live long and prosper.......